Celularity Inc. (NASDAQ:CELU) finished Wednesday with an addition of $0.12 to close at $1.02, an upside of 13.21 percent. An average of 1,316,340 shares of common stock have been traded in the last five days. There was a fall of -$0.1100 in the past week, and it reached a new high 24 times over the past 12 months. The last 20 days have seen an average of 646,290 shares traded, while the 50-day average volume stands at 524,674.
CELU stock has decreased by -34.19% in the last month. The company shares reached their 1-month lowest point of $0.8902 on 01/06/23. With the stock rallying to its 52-week high on 01/03/23, shares of the company touched a low of $0.89 and a high of $13.19 in 52 weeks. It has reached a new high 1 time so far this year and lost -20.93% or -$0.2700 in price. In spite of this, the price is down -92.26% from the 52-week high.
Celularity Inc. (CELU) stock’s beta is 0.34. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 8.07, the price-to-book (PB) ratio at 0.89.
The quick ratio of Celularity Inc. for the three months ended September 29 was 0.80, and the current ratio was 0.90, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.24 for the quarter ending September 29. Its gross profit as reported stood at $11.68 million compared to revenue of $21.34 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Celularity Inc.’s return on assets was -3.30%.
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $4.8 million in the quarter, while revenues of $47.83 million were shrunk -940.42%. The analyst consensus anticipated Celularity Inc.’s latest quarter earnings to come in at -$0.26 per share, but it turned out to be $0.03, a 111.50% surprise. For the quarter, EBITDA amounted to -$3.25 million. Shareholders own equity worth $145.01 million.
From a technical analysis perspective, let’s take a brief look at Celularity Inc. (CELU) price momentum. RSI 9-day as of the close on 11 January was 39.15%, suggesting the stock is Neutral, with historical volatility in this time frame at 140.89%.
As of today, CELU’s price is $0.9541 -9.73% or -$0.1100 from its 5-day moving average. CELU is currently trading -37.80% lower than its 20-day SMA and -64.83% lower than its 100-day SMA. However, the stock’s current price level is -56.41% below the SMA50 and -86.14% below the SMA200.
The stochastic %K and %D were 11.53% and 8.47%, respectively, and the average true range (ATR) was 0.1517. With the 14-day stochastic at 25.97% and the average true range at 0.1569, the RSI (14) stands at 36.98%. The stock has reached -0.1126 on the 9-day MACD Oscillator while the 14-day reading was at -0.1468.
Oppenheimer downgraded Celularity Inc. (NASDAQ: CELU) to a a Perform rating in its most recent analyst report. Previously, the stock was rated as an Outperform. The consensus rating for Celularity Inc. (CELU) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CELU, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.
What is CELU’s price target for the next 12 months?
Analysts predict a range of price targets between $5.00 and $15.00, with a median target of $10.50. Taking a look at these predictions, the average price target given by analysts for Celularity Inc. (CELU) stock is $10.25.